BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

745 related articles for article (PubMed ID: 29562882)

  • 1. Low HLA binding of diabetes-associated CD8+ T-cell epitopes is increased by post translational modifications.
    Sidney J; Vela JL; Friedrich D; Kolla R; von Herrath M; Wesley JD; Sette A
    BMC Immunol; 2018 Mar; 19(1):12. PubMed ID: 29562882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD8 T cell autoreactivity to preproinsulin epitopes with very low human leucocyte antigen class I binding affinity.
    Abreu JR; Martina S; Verrijn Stuart AA; Fillié YE; Franken KL; Drijfhout JW; Roep BO
    Clin Exp Immunol; 2012 Oct; 170(1):57-65. PubMed ID: 22943201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunology of Diabetes Society T-Cell Workshop: HLA class I tetramer-directed epitope validation initiative T-Cell Workshop Report-HLA Class I Tetramer Validation Initiative.
    Mallone R; Scotto M; Janicki CN; James EA; Fitzgerald-Miller L; Wagner R; Gottlieb P; Thorpe J; Jospe N; Durinovic-Bellò I; Boitard C; Lou O; Dayan CM; Wong FS;
    Diabetes Metab Res Rev; 2011 Nov; 27(8):720-6. PubMed ID: 22069251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of low-affinity preproinsulin epitopes and detection of autoreactive CD8 T-cells using combinatorial MHC multimers.
    Unger WW; Velthuis J; Abreu JR; Laban S; Quinten E; Kester MG; Reker-Hadrup S; Bakker AH; Duinkerken G; Mulder A; Franken KL; Hilbrands R; Keymeulen B; Peakman M; Ossendorp F; Drijfhout JW; Schumacher TN; Roep BO
    J Autoimmun; 2011 Nov; 37(3):151-9. PubMed ID: 21636247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Mimicry of Viral and Pancreatic β Cell Antigens Through Non-Spliced and
    Mishto M; Mansurkhodzhaev A; Rodriguez-Calvo T; Liepe J
    Front Immunol; 2021; 12():656451. PubMed ID: 33936085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition of HLA class I-restricted beta-cell epitopes in type 1 diabetes.
    Ouyang Q; Standifer NE; Qin H; Gottlieb P; Verchere CB; Nepom GT; Tan R; Panagiotopoulos C
    Diabetes; 2006 Nov; 55(11):3068-74. PubMed ID: 17065344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of HLA class I-restricted T-cell epitopes of islet autoantigen combined with binding and dissociation assays.
    Wu X; Xu X; Gu R; Wang Z; Chen H; Xu K; Zhang M; Hutton J; Yang T
    Autoimmunity; 2012 Mar; 45(2):176-85. PubMed ID: 22260783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating β cell-specific CD8
    Yeo L; Pujol-Autonell I; Baptista R; Eichmann M; Kronenberg-Versteeg D; Heck S; Dolton G; Sewell AK; Härkönen T; Mikk ML; Toppari J; Veijola R; Knip M; Ilonen J; Peakman M
    Clin Exp Immunol; 2020 Mar; 199(3):263-277. PubMed ID: 31660582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human MHC class I transgenic mice deficient for H2 class I expression facilitate identification and characterization of new HLA class I-restricted viral T cell epitopes.
    Cheuk E; D'Souza C; Hu N; Liu Y; Lang H; Chamberlain JW
    J Immunol; 2002 Nov; 169(10):5571-80. PubMed ID: 12421934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond HLA-A*0201: new HLA-transgenic nonobese diabetic mouse models of type 1 diabetes identify the insulin C-peptide as a rich source of CD8+ T cell epitopes.
    Antal Z; Baker JC; Smith C; Jarchum I; Babad J; Mukherjee G; Yang Y; Sidney J; Sette A; Santamaria P; DiLorenzo TP
    J Immunol; 2012 Jun; 188(11):5766-75. PubMed ID: 22539795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic Cells Guide Islet Autoimmunity through a Restricted and Uniquely Processed Peptidome Presented by High-Risk HLA-DR.
    van Lummel M; van Veelen PA; de Ru AH; Janssen GM; Pool J; Laban S; Joosten AM; Nikolic T; Drijfhout JW; Mearin ML; Aanstoot HJ; Peakman M; Roep BO
    J Immunol; 2016 Apr; 196(8):3253-63. PubMed ID: 26944932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of MHC class II restricted T-cell-mediated reactivity against MHC class I binding Mycobacterium tuberculosis peptides.
    Wang M; Tang ST; Stryhn A; Justesen S; Larsen MV; Dziegiel MH; Lewinsohn DM; Buus S; Lund O; Claesson MH
    Immunology; 2011 Apr; 132(4):482-91. PubMed ID: 21294723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conventional and Neo-antigenic Peptides Presented by β Cells Are Targeted by Circulating Naïve CD8+ T Cells in Type 1 Diabetic and Healthy Donors.
    Gonzalez-Duque S; Azoury ME; Colli ML; Afonso G; Turatsinze JV; Nigi L; Lalanne AI; Sebastiani G; Carré A; Pinto S; Culina S; Corcos N; Bugliani M; Marchetti P; Armanet M; Diedisheim M; Kyewski B; Steinmetz LM; Buus S; You S; Dubois-Laforgue D; Larger E; Beressi JP; Bruno G; Dotta F; Scharfmann R; Eizirik DL; Verdier Y; Vinh J; Mallone R
    Cell Metab; 2018 Dec; 28(6):946-960.e6. PubMed ID: 30078552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classically restricted human CD8+ T lymphocytes derived from Mycobacterium tuberculosis-infected cells: definition of antigenic specificity.
    Lewinsohn DM; Zhu L; Madison VJ; Dillon DC; Fling SP; Reed SG; Grabstein KH; Alderson MR
    J Immunol; 2001 Jan; 166(1):439-46. PubMed ID: 11123322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analyzing the effect of peptide-HLA-binding ability on the immunogenicity of potential CD8+ and CD4+ T cell epitopes in a large dataset.
    Wang S; Li J; Chen X; Wang L; Liu W; Wu Y
    Immunol Res; 2016 Aug; 64(4):908-18. PubMed ID: 27094547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-presentation of HLA class I epitopes from exogenous NY-ESO-1 polypeptides by nonprofessional APCs.
    Gnjatic S; Atanackovic D; Matsuo M; Jäger E; Lee SY; Valmori D; Chen YT; Ritter G; Knuth A; Old LJ
    J Immunol; 2003 Feb; 170(3):1191-6. PubMed ID: 12538675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of a Selective Islet Peptidome Presented by the Highest-Risk HLA-DQ8trans Molecule.
    van Lummel M; van Veelen PA; de Ru AH; Pool J; Nikolic T; Laban S; Joosten A; Drijfhout JW; Gómez-Touriño I; Arif S; Aanstoot HJ; Peakman M; Roep BO
    Diabetes; 2016 Mar; 65(3):732-41. PubMed ID: 26718497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigens.
    Mortier MC; Jongert E; Mettens P; Ruelle JL
    BMC Immunol; 2015 Oct; 16():63. PubMed ID: 26493839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of HLA-A2-restricted immunogenic peptides derived from Vitamin D-Binding Protein.
    Zhang M; Lu G; Meng F; Li S; Li X; Gong X
    Cell Immunol; 2018 Jun; 328():18-23. PubMed ID: 29549963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficiency and mechanism of antigen-specific CD8+ T-cell activation using synthetic long peptides.
    Zandvliet ML; Kester MG; van Liempt E; de Ru AH; van Veelen PA; Griffioen M; Guchelaar HJ; Falkenburg JH; Meij P
    J Immunother; 2012; 35(2):142-53. PubMed ID: 22306902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.